FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220928664> ?p ?o ?g. }

• W4220928664 endingPage "3150" @default.
• W4220928664 startingPage "3150" @default.
• W4220928664 abstract "Proline-rich antimicrobial peptides (PrAMPs) are promising candidates to treat bacterial infections. The designer peptide ARV-1502 exhibits strong antimicrobial effects against Enterobacteriaceae both in vitro and in vivo. Since the inhibitory effects of ARV-1502 reported for the 70 kDa heat-shock protein DnaK do not fully explain the antimicrobial activity of its 176 substituted analogs, we further studied their effect on the bacterial 70S ribosome of Escherichia coli, a known target of PrAMPs. ARV-1502 analogues, substituted in positions 3, 4, and 8 to 12 (underlined) of the binding motif D3KPRPYLPRP12 with aspartic acid, lysine, serine, phenylalanine or leucine, were tested in a competitive fluorescence polarization (FP) binding screening assay using 5(6)-carboxyfluorescein-labeled (Cf-) ARV-1502 and the 70S ribosome isolated from E. coli BW25113. While their effect on ribosomal protein expression was studied for green fluorescent protein (GFP) in a cell-free expression system (in vitro translation), the importance of known PrAMP transporters SbmA and MdtM was investigated using E. coli BW25113 and the corresponding knockout mutants. The dissociation constant (Kd) of 201 ± 16 nmol/L obtained for Cf-ARV-1502 suggests strong binding to the E. coli 70S ribosome. An inhibitory binding assay indicated that the binding site overlaps with those of other PrAMPs including Onc112 and pyrrhocoricin as well as the non-peptidic antibiotics erythromycin and chloramphenicol. All these drugs and drug candidates bind to the exit-tunnel of the 70S ribosome. Substitutions of the C-terminal fragment of the binding motif YLPRP reduced binding. At the same time, inhibition of GFP expression increased with net peptide charge. Interestingly, the MIC values of wild-type and ΔsbmA and ΔmdtM knockout mutants indicated that substitutions in the ribosomal binding motif altered also the bacterial uptake, which was generally improved by incorporation of hydrophobic residues. In conclusion, most substituted ARV-1502 analogs bound weaker to the 70S ribosome than ARV-1502 underlining the importance of the YLPRP binding motif. The weaker ribosomal binding correlated well with decreased antimicrobial activity in vitro. Substituted ARV-1502 analogs with a higher level of hydrophobicity or positive net charge improved the ribosome binding, inhibition of translation, and bacterial uptake." @default.
• W4220928664 created "2022-04-03" @default.
• W4220928664 creator A5003323107 @default.
• W4220928664 creator A5021683627 @default.
• W4220928664 creator A5051860064 @default.
• W4220928664 creator A5062304724 @default.
• W4220928664 creator A5083730419 @default.
• W4220928664 creator A5088154981 @default.
• W4220928664 date "2022-03-15" @default.
• W4220928664 modified "2023-09-27" @default.
• W4220928664 title "Influence of Substitutions in the Binding Motif of Proline-Rich Antimicrobial Peptide ARV-1502 on 70S Ribosome Binding and Antimicrobial Activity" @default.
• W4220928664 cites W1813533336 @default.
• W4220928664 cites W1893407452 @default.
• W4220928664 cites W1894942982 @default.
• W4220928664 cites W1939757033 @default.
• W4220928664 cites W1968625612 @default.
• W4220928664 cites W1977276752 @default.
• W4220928664 cites W1978600513 @default.
• W4220928664 cites W1988092390 @default.
• W4220928664 cites W1995412010 @default.
• W4220928664 cites W2007524080 @default.
• W4220928664 cites W2012115019 @default.
• W4220928664 cites W2048137852 @default.
• W4220928664 cites W2057874299 @default.
• W4220928664 cites W2058118546 @default.
• W4220928664 cites W2060421156 @default.
• W4220928664 cites W2074703948 @default.
• W4220928664 cites W2074858437 @default.
• W4220928664 cites W2100671135 @default.
• W4220928664 cites W2102532232 @default.
• W4220928664 cites W2105751124 @default.
• W4220928664 cites W2133095427 @default.
• W4220928664 cites W2135533782 @default.
• W4220928664 cites W2158988420 @default.
• W4220928664 cites W2161816711 @default.
• W4220928664 cites W2257180174 @default.
• W4220928664 cites W2259422506 @default.
• W4220928664 cites W2290257677 @default.
• W4220928664 cites W2297420302 @default.
• W4220928664 cites W2319715014 @default.
• W4220928664 cites W2503595204 @default.
• W4220928664 cites W2619787325 @default.
• W4220928664 cites W2735523552 @default.
• W4220928664 cites W2738678411 @default.
• W4220928664 cites W2913672362 @default.
• W4220928664 cites W2936102562 @default.
• W4220928664 cites W3001277296 @default.
• W4220928664 cites W3015265554 @default.
• W4220928664 cites W4200213235 @default.
• W4220928664 cites W4210930762 @default.
• W4220928664 doi "https://doi.org/10.3390/ijms23063150" @default.
• W4220928664 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35328571" @default.
• W4220928664 hasPublicationYear "2022" @default.
• W4220928664 type Work @default.
• W4220928664 citedByCount "4" @default.
• W4220928664 countsByYear W42209286642022 @default.
• W4220928664 countsByYear W42209286642023 @default.
• W4220928664 crossrefType "journal-article" @default.
• W4220928664 hasAuthorship W4220928664A5003323107 @default.
• W4220928664 hasAuthorship W4220928664A5021683627 @default.
• W4220928664 hasAuthorship W4220928664A5051860064 @default.
• W4220928664 hasAuthorship W4220928664A5062304724 @default.
• W4220928664 hasAuthorship W4220928664A5083730419 @default.
• W4220928664 hasAuthorship W4220928664A5088154981 @default.
• W4220928664 hasBestOaLocation W42209286641 @default.
• W4220928664 hasConcept C104317684 @default.
• W4220928664 hasConcept C107824862 @default.
• W4220928664 hasConcept C178790620 @default.
• W4220928664 hasConcept C185592680 @default.
• W4220928664 hasConcept C202751555 @default.
• W4220928664 hasConcept C2779281246 @default.
• W4220928664 hasConcept C4937899 @default.
• W4220928664 hasConcept C540938839 @default.
• W4220928664 hasConcept C547475151 @default.
• W4220928664 hasConcept C55493867 @default.
• W4220928664 hasConcept C67705224 @default.
• W4220928664 hasConcept C88478588 @default.
• W4220928664 hasConceptScore W4220928664C104317684 @default.
• W4220928664 hasConceptScore W4220928664C107824862 @default.
• W4220928664 hasConceptScore W4220928664C178790620 @default.
• W4220928664 hasConceptScore W4220928664C185592680 @default.
• W4220928664 hasConceptScore W4220928664C202751555 @default.
• W4220928664 hasConceptScore W4220928664C2779281246 @default.
• W4220928664 hasConceptScore W4220928664C4937899 @default.
• W4220928664 hasConceptScore W4220928664C540938839 @default.
• W4220928664 hasConceptScore W4220928664C547475151 @default.
• W4220928664 hasConceptScore W4220928664C55493867 @default.
• W4220928664 hasConceptScore W4220928664C67705224 @default.
• W4220928664 hasConceptScore W4220928664C88478588 @default.
• W4220928664 hasFunder F4320320300 @default.
• W4220928664 hasFunder F4320332161 @default.
• W4220928664 hasIssue "6" @default.
• W4220928664 hasLocation W42209286641 @default.
• W4220928664 hasLocation W42209286642 @default.
• W4220928664 hasLocation W42209286643 @default.
• W4220928664 hasOpenAccess W4220928664 @default.
• W4220928664 hasPrimaryLocation W42209286641 @default.
• W4220928664 hasRelatedWork W1985134361 @default.

• next